MURPHY ANDREW J (EVP Research) received a stock award from REGENERON PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/9/2025ACC: 0001796226-25-000007
Officer· EVP Research
Since Dec 2019
+20.33K
Net shares
Net buyer
$1.21M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
22.03K acquired · 1.70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.71K
Price / share
—
Trade value
—
% of position
7.4%
12/5/2025
50.05K→53.76K
Common Stock
Direct
Shares
−1.70K
Price / share
$712.94
Trade value
$1.21M
% of position
3.2%
12/8/2025
53.76K→52.06K
Total
Net shares
+2.02K
Net value
-$1.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | A · Award | +3.71K | — | — | 7.4% | 50.05K | 53.76K |
| Common Stock Direct | 12/8/2025 | F · Tax Withholding | −1.70K | $712.94 | $1.21M | 3.2% | 53.76K | 52.06K |
| Total | +2.02K | -$1.21M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
18.32K shares
Shares
+18.32K
Strike price
726.71
Held after
18.32K
Exercisable
—
12/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock18.32K shares | 12/5/2025 | A · Award | +18.32K | 726.71 | — | 18.32K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.38K
Total
4.38K indirect4.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.38K | Indirect |
| Total | 4.38K | 4.38K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported